Read Scientific Limited 04663148 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is repairing scientific instruments. Digita Accounts Production Advanced 6.30.9574.0 true true 04663148 2023-04-01 2024-03-31 04663148 2024-03-31 04663148 bus:OrdinaryShareClass1 2024-03-31 04663148 bus:OrdinaryShareClass2 2024-03-31 04663148 core:CurrentFinancialInstruments 2024-03-31 04663148 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 04663148 core:Goodwill 2024-03-31 04663148 core:FurnitureFittings 2024-03-31 04663148 core:PlantMachinery 2024-03-31 04663148 bus:SmallEntities 2023-04-01 2024-03-31 04663148 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 04663148 bus:FilletedAccounts 2023-04-01 2024-03-31 04663148 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 04663148 bus:RegisteredOffice 2023-04-01 2024-03-31 04663148 bus:Director1 2023-04-01 2024-03-31 04663148 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 04663148 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 04663148 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 04663148 core:Goodwill 2023-04-01 2024-03-31 04663148 core:FurnitureFittings 2023-04-01 2024-03-31 04663148 core:PlantMachinery 2023-04-01 2024-03-31 04663148 countries:EnglandWales 2023-04-01 2024-03-31 04663148 2023-03-31 04663148 core:Goodwill 2023-03-31 04663148 core:FurnitureFittings 2023-03-31 04663148 core:PlantMachinery 2023-03-31 04663148 2022-04-01 2023-03-31 04663148 2023-03-31 04663148 bus:OrdinaryShareClass1 2023-03-31 04663148 bus:OrdinaryShareClass2 2023-03-31 04663148 core:CurrentFinancialInstruments 2023-03-31 04663148 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 04663148 core:FurnitureFittings 2023-03-31 04663148 core:PlantMachinery 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 04663148

Read Scientific Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

Read Scientific Limited

Contents

Company Information

1

Statement of financial position

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Read Scientific Limited

Company Information

Director

Mr William Read

Registered office

19 King Street
King's Lynn
Norfolk
PE30 1HB

Accountants

Hayhow & Co
Chartered Certified Accountants & Business Advisers
19 King Street
King's Lynn
Norfolk
PE30 1HB

 

Read Scientific Limited

(Registration number: 04663148)
Statement of financial position as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

5

1,042

1,017

Current assets

 

Stocks

6

12,925

10,343

Debtors

7

20,039

39,349

Cash at bank and in hand

 

115,404

103,445

 

148,368

153,137

Creditors: Amounts falling due within one year

8

(59,633)

(58,707)

Net current assets

 

88,735

94,430

Total assets less current liabilities

 

89,777

95,447

Provisions for liabilities

(188)

(193)

Net assets

 

89,589

95,254

Capital and reserves

 

Called up share capital

9

100

100

Retained earnings

89,489

95,154

Shareholders' funds

 

89,589

95,254

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Statement of comprehensive income.

Approved and authorised by the director on 11 December 2024
 

 

Read Scientific Limited

(Registration number: 04663148)
Statement of financial position as at 31 March 2024

.........................................
Mr William Read
Director

 

Read Scientific Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
19 King Street
King's Lynn
Norfolk
PE30 1HB

These financial statements were authorised for issue by the director on 11 December 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Read Scientific Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

25% reducing balance

Fixtures and fittings

25% reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

5% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Read Scientific Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 2).

 

Read Scientific Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 April 2023

30,000

30,000

At 31 March 2024

30,000

30,000

Amortisation

At 1 April 2023

30,000

30,000

At 31 March 2024

30,000

30,000

Carrying amount

At 31 March 2024

-

-

5

Tangible assets

Fixtures and fittings
£

Plant and machinery
£

Total
£

Cost or valuation

At 1 April 2023

9,806

5,204

15,010

Additions

374

-

374

At 31 March 2024

10,180

5,204

15,384

Depreciation

At 1 April 2023

8,862

5,131

13,993

Charge for the year

331

18

349

At 31 March 2024

9,193

5,149

14,342

Carrying amount

At 31 March 2024

987

55

1,042

At 31 March 2023

944

73

1,017

6

Stocks

2024
£

2023
£

Raw materials and consumables

12,925

10,343

 

Read Scientific Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

7

Debtors

Current

2024
£

2023
£

Trade debtors

19,940

39,260

Prepayments

99

89

 

20,039

39,349

8

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Amounts due to related parties

41,368

33,459

Social security and other taxes

 

13,550

12,357

Accruals

 

1,800

1,750

Tax liability

2,915

11,141

 

59,633

58,707

9

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary A of £1 each

75

75

75

75

Ordinary B of £1 each

25

25

25

25

100

100

100

100

Each share is entitled to one vote in any circumstances and each share is also entitled pari passu to dividend payments or any other distribution, including a distribution arising from a winding up of the company.